NPI: 1952364648 · GARY, IN 46408 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/11/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/11/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 66,510 | $399K |
| 2019 | 48,290 | $414K |
| 2020 | 39,749 | $425K |
| 2021 | 22,699 | $306K |
| 2022 | 13,754 | $273K |
| 2023 | 5,060 | $250K |
| 2024 | 4,391 | $204K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 68,236 | 4,136 | $2.14M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 59,955 | 2,382 | $108K |
| J1756 | Injection, iron sucrose, 1 mg | 11,769 | 2,280 | $15K |
| J1270 | Injection, doxercalciferol, 1 mcg | 34,483 | 2,137 | $7K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 199 | 75 | $4K |
| 83970 | 3,422 | 2,286 | $330.68 | |
| 85041 | 2,686 | 1,873 | $146.09 | |
| 85048 | 2,671 | 1,862 | $116.45 | |
| 85045 | 2,556 | 1,822 | $114.35 | |
| 82728 | 1,823 | 1,223 | $53.12 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 740 | 517 | $50.09 |
| A4657 | Syringe, with or without needle, each | 6,040 | 2,492 | $38.51 |
| 0124A | 18 | 13 | $36.90 | |
| 83550 | 1,809 | 1,205 | $34.85 | |
| 82108 | 206 | 151 | $30.26 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 591 | 342 | $27.36 |
| 83540 | 1,824 | 1,211 | $27.26 | |
| 82947 | 84 | 53 | $2.55 | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 1,104 | 365 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 126 | 86 | $0.00 |
| 0012A | 19 | 18 | $0.00 | |
| 90674 | 73 | 45 | $0.00 | |
| 0011A | 19 | 18 | $0.00 |